Adiposity and glycemic control in children exposed to perfluorinated compounds

Clara Amalie G Timmermann1, Laura I Rossing, Anders Grøntved

  • 1Department of Environmental Medicine, Institute of Public Health (C.A.G.T., L.I.R., C.D., P.G., F.N., T.K.J.), and Institute of Sports Science and Clinical Biomechanics (A.G., M.R.-L., L.B.A.), University of Southern Denmark, 5000 Odense C, Denmark; and Department of Biostatistics (K.D.S., T.S.), University of Copenhagen, 1353 Copenhagen, Denmark.

Insights

Childhood exposure to perfluorinated and polyfluorinated compounds (PFCs) was linked to higher insulin and triglyceride levels in overweight children. These findings in 8- to 10-year-olds require confirmation in longitudinal studies.

Area of Science:

  • Environmental Health
  • Pediatric Endocrinology
  • Toxicology

Background:

  • Perfluorinated and polyfluorinated compounds (PFCs) are widely used industrial chemicals.
  • Concerns exist regarding the potential health effects of PFCs on children's metabolic health.
  • Childhood obesity and metabolic dysfunction are significant public health issues.

Purpose of the Study:

  • To investigate the association between childhood exposure to PFCs and adiposity.
  • To examine the relationship between PFC exposure and markers of glycemic control in children.

Main Methods:

  • A subset of the European Youth Heart Study (Danish component) involving 499 children aged 8-10 years was analyzed.
  • Measurements included body mass index, skinfold thickness, waist circumference, leptin, adiponectin, insulin, glucose, and triglyceride levels.
  • Plasma PFC concentrations were measured, and linear regression models were used to assess associations.

Main Results:

  • No association was found between PFC exposure and adiposity or glycemic control markers in normal-weight children.
  • In overweight children, increased perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) plasma concentrations were significantly associated with higher insulin, beta-cell activity/function, insulin resistance, and triglyceride levels.

Conclusions:

  • Childhood exposure to higher levels of certain PFCs is associated with adverse metabolic markers in overweight children.
  • The cross-sectional design limits causal inference, and reverse causation cannot be ruled out.
  • Further longitudinal studies are necessary to confirm these findings and understand the long-term implications.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K